
Professor Peter Van Der Meer
University Medical Centre Groningen, Groningen (Netherlands (The))
Membership:
FESC Member
HFA Member
Biography
Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and professor of Heart Failure and Translational Cardiology at the University of Groningen.
Professor van der Meer received both his MD and PhD cum laude and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of >100 and was member of the 2022 ESC CardioOncology guidelines and is member of the ESC/HFA working group on PeriPartum CardioMyopathy. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics. His research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.
Contributor content
Session
New insights from animal models of heart failure and cardiomyopathy
11 May 2026
Session
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
11 May 2026
Session
Late-Breaking Clinical Science: spectrum of cardiomyopathies
31 August 2025
Session
Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?
30 August 2025
Session
Into the fold: multidisciplinary approaches to managing light chain (AL) amyloidosis
21 June 2025
Session
The year in cardio-oncology 2025
20 June 2025
Session
Latest advances in radiation therapy
20 June 2025
Session
Clinical trials updates in medical therapy
19 May 2025
Session
Beating the odds: advances in cardiac amyloidosis treatment
18 May 2025
Session
Cardio-oncology: when therapy leads to failure
17 May 2025

